SCHEMBL25758845

SCHEMBL25758845

CC(C)NC(=O)c1cc2ccc(F)c(Br)c2[nH]1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 2/20 0.54
EIF4A3 P38919 1/20 0.43
AR P10275 1/20 0.40
ALPL P05186 2/20 0.38
ALB P02768 1/20 0.38
IL2 P60568 1/20 0.38
NPC1 O15118 2/20 0.38
RAB9A P51151 2/20 0.38
POLB P06746 2/20 0.38
RXFP1 Q9HBX9 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
MAPT P10636 3/20 0.38
THRB P10828 1/20 0.38
MAPK1 P28482 1/20 0.38
ADORA3 P0DMS8 1/20 0.37
ADORA2A P29274 1/20 0.37
ADORA2B P29275 1/20 0.37
ADORA1 P30542 1/20 0.37
PTK2 Q05397 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25758822 0.86 ALOX15 (0.57) ALOX15EIF4A3ARALPLALB
SCHEMBL24740347 0.84 ALOX15 (0.61) ALOX15EIF4A3ARALPLALB
SCHEMBL24019700 0.81 ALB (0.55) ALOX15ARALBIL2NPC1
SCHEMBL25758838 0.80 ALOX15 (0.46) ALOX15ALPLALBIL2MEN1
SCHEMBL25758821 0.79 IDO1 (0.50) ALOX15EIF4A3ALPLALBIL2
SCHEMBL24019964 0.78 ALOX15 (0.58) ALOX15EIF4A3ARALPLPOLB
SCHEMBL24112573 0.78 EIF4A3 (0.54) EIF4A3MEN1KMT2AMAPTKDM4E
SCHEMBL25758841 0.78 XDH (0.49) ALOX15EIF4A3ARALPLNPC1
SCHEMBL29062816 0.77 MAP2K1 (0.43) EIF4A3NPC1RAB9APOLBRXFP1
SCHEMBL24019762 0.75 ALOX15 (0.60) ALOX15EIF4A3ALPLPOLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212152-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF Pardes Biosciences, Inc. 2023-07-06 US disclosed
US-20230212152-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF Pardes Biosciences, Inc. 2023-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230212152-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF CTRL, CTSL, CTSV ALOX15 1455/4885EIF4A3 582/4885AR 4727/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.